Medico Remedies Limited (BOM:540937)

India flag India · Delayed Price · Currency is INR
38.15
-1.67 (-4.19%)
At close: Aug 28, 2025
-4.19%
Market Cap3.17B
Revenue (ttm)1.58B
Net Income (ttm)103.33M
Shares Out82.98M
EPS (ttm)1.25
PE Ratio30.64
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25,900
Average Volume26,174
Open41.50
Previous Close39.82
Day's Range38.00 - 41.50
52-Week Range35.00 - 79.78
Beta0.02
RSI40.94
Earnings DateAug 8, 2025

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 213
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540937
Full Company Profile

Financial Performance

In 2024, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.

Financial Statements

News

There is no news available yet.